We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
-40.91%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$93.7M
AUM Growth
-$106M
Cap. Flow
-$9.06M
Cap. Flow %
-9.67%
Top 10 Hldgs %
99.15%
Holding
12
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$9.06M

Sector Composition

Rank Sector Weight
1 Healthcare 64.57%
2 Communication Services 29.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDLX icon
1
Cardlytics
CDLX
$22.1M
$27.6M 29.51%
255,263
– –
FATE icon
2
Fate Therapeutics
FATE
$293M
$23.4M 24.97%
1,823,186
-650,000
-26% -$9.06M
STIM icon
3
Neuronetics
STIM
$137M
$16M 17.04%
824,765
– –
KALA icon
4
KALA BIO
KALA
$13.6M
$9.08M 9.7%
744
– –
TTOO
5
DELISTED
T2 Biosystems, Inc
TTOO
$5.54M 5.92%
368
– –
XFOR icon
6
X4 Pharmaceuticals
XFOR
$377M
$4.34M 4.63%
10,383
– –
RNAC icon
7
Cartesian Therapeutics
RNAC
$227M
$4.27M 4.56%
53,560
– –
ATYR
8
aTyr Pharma
ATYR
$47.1M
$906K 0.97%
130,571
– –
TRVN
9
DELISTED
Trevena, Inc.
TRVN
$883K 0.94%
3,286
– –
PULM icon
10
Pulmatrix
PULM
$6.21M
$863K 0.92%
17,972
– –
GNCA
11
DELISTED
Genocea Biosciences, Inc.
GNCA
$565K 0.6%
246,076
– –
DARE icon
12
Dare Bioscience
DARE
$18.6M
$232K 0.25%
27,187
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q4 2018 Portfolio in Review

As of Q4 2018, Polaris Venture Management Co V held 12 positions worth $93.7M, down 53% from $200M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Polaris Venture Management Co V withdrew a net $9.06M in Q4 2018, reducing 1 holding. Its largest reduction was Fate Therapeutics, cutting an estimated $9.06M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 61% a quarter earlier, followed by Communication Services.

  • Polaris Venture Management Co V's biggest Q4 2018 reduction was Fate Therapeutics, cutting an estimated $9.06M.
  • Polaris Venture Management Co V's ten largest holdings make up 99% of its $93.7M portfolio in Q4 2018.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q4 2018.
  • Polaris Venture Management Co V's portfolio value fell 53% quarter-over-quarter to $93.7M.

Based on Polaris Venture Management Co V's 13F filing for Q4 2018, filed 14 Feb 2019.